SEC Comment Letter 0000000000-25-002368 to GH Research PLC (GHRS) (CIK 0001855129) (GHRS)
GH Research PLC (GHRS) (CIK 0001855129)
Date: March 3, 2025 · CIK: 0001855129 · Accession: 0000000000-25-002368
AI Filing Summary & Sentiment
File numbers found in text: 333-285310
Letter
March 3, 2025 Velichka Valcheva Chief Executive Officer GH Research PLC Joshua Dawson House Dawson Street Dublin 2 D02 RY95 Ireland Re:GH Research PLC Registration Statement on Form F-3 Filed February 27, 2025 File No. 333-285310 Dear Velichka Valcheva: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Daniel Crawford at 202-551-7767 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Yasin Keshvargar, Esq.
Show Raw Text
March 3, 2025
Velichka Valcheva
Chief Executive Officer
GH Research PLC
Joshua Dawson House
Dawson Street
Dublin 2
D02 RY95
Ireland
Re:GH Research PLC
Registration Statement on Form F-3
Filed February 27, 2025
File No. 333-285310
Dear Velichka Valcheva:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Daniel Crawford at 202-551-7767 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Yasin Keshvargar, Esq.